Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenishaw Regulatory News (RSW)

Share Price Information for Renishaw (RSW)

Share Price is delayed by 15 minutes
Get Live Data
5,240.00    25.00 (0.48%)
Bid:
5,270.00
Ask:
5,280.00
Spread: 10.00 (0.19%)
Market Cap: £3.81b
RSW Live PriceLast checked at - London Stock Exchange

Intraday Renishaw Share Chart

Trading Statement

14 May 2019 07:00

RNS Number : 8774Y
Renishaw PLC
14 May 2019
 

Renishaw plc

Trading update

14 May 2019

 

Renishaw plc, the global high-precision metrology and healthcare technology group, publishes this trading update for the nine months ended 31 March 2019. It contains unaudited information that covers the first three quarters of the financial year and the period since. As previously announced, the Company is hosting its annual investor day today.

 

Trading activity

 

Continuing operations

9 months to 31 March 2019

9 months to 31 March 2018

Change

Metrology

£404.5m

£406.6m

-0.5%

Healthcare

£26.6m

£23.3m

14.2%

Total Revenue

£431.1m

£429.9m

0.3%

 

 

 

Adjusted* Profit before tax

£79.6m

£97.6m

-18.4%

Statutory Profit before tax

£84.8m

£104.4m

-18.8%

 

Revenue from continuing operations for the first three quarters of the current financial year was £431.1m, an increase of 0.3% compared with £429.9m for the corresponding period last year.

 

Metrology revenue for the nine months to 31 March 2019 amounted to £404.5m compared with £406.6m for the same period last year. Revenue in our healthcare business has grown to £26.6m compared to £23.3m for the same period last year, an increase of 14.2%.

 

Adjusted profit before tax from continuing operations for the first three quarters amounted to £79.6m compared with an adjusted profit before tax of £97.6m for the corresponding period last year. Statutory profit before tax amounted to £84.8m (2018: £104.4m).

 

Financial position 

The Group balance sheet remains strong with net cash balances of £120.5m as at 31 March 2019 (30 June 2018: £103.8m).

 

Outlook

Based on recent order trends and customer feedback, we now expect full year revenue to be in the range of £580m to £600m. Adjusted profit before tax is now expected to be in the range of £105m to £120m and statutory profit before tax in the range of £111m to £126m. We continue to focus on increasing productivity and on-going investment in the business for the long term.

 

Notwithstanding the current economic uncertainties, the Board remains confident in the future prospects of the Group.

 

The preliminary full year results for the year ending 30 June 2019 will be released on 1 August 2019.

 

 

Sir David McMurtry

Will Lee

CBE, RDI, FRS, FREng, CEng, FIMechE

Chief Executive

Executive Chairman

14 May 2019

 

Renishaw plc

Registered office

New Mills, Wotton-under-Edge, Gloucestershire, GL12 8JR

Registered number

01106260

LEI number

21380048ADXM6Z67CT18

Telephone number

01453 524524

Website

www.renishaw.com

 

 

* Adjusted profit before tax

 

 

The adjustment to statutory profit relates to the accounting treatment of certain forward currency contracts used as hedging instruments which do not qualify for hedge accounting as they do not meet the hedge effectiveness criteria set out in the International Accounting Standard IAS39 'Financial Instruments: Recognition and Measurement'. The Board deems that the adjusted profit before tax better reflects the underlying performance of the Group. The following table reconciles statutory profit before tax to adjusted profit before tax:

 

 

£'m

9 months to 31 March 2019

 

9 months to 31 March 2018

 

 

 

 

Adjusted profit before tax from continuing operations

79.6

 

97.6

 

 

 

 

Fair value gains/losses on financial instruments not eligible for hedge accounting

 

 

 

- reported in revenue

4.8

 

2.6

- reported in losses from the fair value of financial instruments

0.4

 

4.2

 

 

 

 

Statutory profit before tax from continuing operations

84.8

 

104.4

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTEAKSDFEANEFF
Date   Source Headline
24th Sep 20207:00 amRNSDirectors' Remuneration Policy – Clarification
22nd Sep 20203:11 pmRNSReplacement Director/PDMR Shareholding
22nd Sep 20202:19 pmRNSDirector/PDMR Shareholding
8th Sep 20204:35 pmRNSDirector/PDMR Shareholding
1st Sep 20207:00 amRNSAnnual Financial Report
27th Aug 20207:00 amRNSDirector/PDMR Shareholding
17th Aug 20203:15 pmRNSDirector/PDMR Shareholding
13th Aug 20207:00 amRNSFinal Results
6th Aug 202010:00 amRNSNotice of Results
17th Jul 20208:06 amRNSTrading Statement
26th Jun 20201:08 pmRNSDirector/PDMR Shareholding
24th Jun 20203:35 pmRNSDirector/PDMR Shareholding
22nd Jun 20204:17 pmRNSDirector/PDMR Shareholding
10th Jun 20202:00 pmRNSDirector/PDMR Shareholding
5th Jun 20207:00 amRNS2020 Final Dividend
12th May 20207:00 amRNSTrading Statement
4th May 202012:00 pmRNSDisclosure of Rights Attached to Equity Shares
2nd Apr 20204:30 pmRNSStatement re 2019 AGM resolution votes
25th Mar 20204:28 pmRNSStatement re Interim dividend
6th Mar 20209:36 amRNSDirector/PDMR Shareholding
27th Feb 20204:47 pmRNSStatement re Interim dividend
30th Jan 20207:00 amRNSHalf-year Report
29th Jan 20205:45 pmRNSChange in Director's Responsibilities
20th Jan 202012:00 pmRNSNotice of Half-year Results
17th Jan 20209:47 amRNSHolding(s) in Company
24th Oct 20193:37 pmRNSResult of AGM
15th Oct 20197:00 amRNSTrading Statement
30th Aug 20193:00 pmRNSPurchase of Shares by Profit Share Trust
21st Aug 20197:00 amRNSAnnual Financial Report
1st Aug 20197:00 amRNSFinal Results
16th Jul 20193:00 pmRNSNotice of Results
25th Jun 20197:00 amRNSDirectorate Change
14th May 201910:00 amRNSDirector Declaration
14th May 20197:00 amRNSTrading Statement
27th Mar 201911:36 amRNSDirector/PDMR Shareholding
22nd Mar 20199:48 amRNSDirector/PDMR Shareholding
21st Mar 20197:00 amRNSTrading Statement
12th Mar 20194:00 pmRNSNotice of Investor Day
31st Jan 20197:00 amRNSHalf-year Report
15th Jan 20193:00 pmRNSNotice of Half-year Results
19th Dec 201810:07 amRNSDirector/PDMR Shareholding
29th Oct 20189:56 amRNSDirector/PDMR Shareholding
23rd Oct 201810:02 amRNSDirector/PDMR Shareholding
22nd Oct 201810:43 amRNSDirector/PDMR Shareholding
18th Oct 20184:02 pmRNSResult of AGM
18th Oct 20187:00 amRNSTrading Statement
23rd Aug 20182:00 pmRNSPurchase of Shares by Profit Share Trust
21st Aug 20187:00 amRNSAnnual Financial Report
3rd Aug 201812:00 pmRNSDirector/PDMR Shareholding
2nd Aug 20183:00 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.